Search
Selected: All

Use of nicotinic analogs for treatment of degenerative diseases

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nicotinic analogs for treatment of degenerative...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitric oxide scavengers to treat side effects caused...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitric oxide scavengers to treat side effects caused...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitric oxide-releasing agents for reducing metastasis ris

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitroderivatives in urinary incontinence

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitroflavonoids for the treatment of anxiety

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitrofurantoin for the treatment and prophylaxis of gastr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitrogen heterocyclic aromatic derivatives in the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitrogen heterocyclic compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitrogen substituted thalidomide analogs for the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitroxides for the treatment of essential hypertension

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nitroxides in wound healing and in the prevention of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of NK-1 receptor antagonists for treating mania

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of NK.sub.1 receptor antagonists for preparing cardio-regula

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of non-peptide bradykinin antagonists for the treatment or p

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of non-steroidal antiiflammatory agents in macular degenerat

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of nonpeptide bradykinin antagonists for the treatment and p

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of NR2B-selective NMDA-receptor antagonists for the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of O-substituted derivatives of (+)-cyanidan-3-ol as compoun

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.